16
1
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T71175 |
SCD1 Inhibitor
|
Others | Others |
SCD1 Inhibitor is a novel stearoyl-CoA desaturase1 (SCD1) inhibitor. | |||
T38683 |
SCD1 inhibitor-3
SCD1-IN-3,SCD1 inhibitor-3,SCD1 inhibitor 17a |
Dehydrogenase | Metabolism |
SCD1 inhibitor-3 (ML-270) 是一种高效、口服的化合物,可以抑制SCD1,且安全性极高。 SCD1 inhibitor-3 显示出在代谢疾病(包括肥胖、二型糖尿病和血脂异常,以及痤疮和癌症等各种皮肤病)方面的巨大研究潜力。 | |||
T10525 |
SCD1 inhibitor-4
|
Dehydrogenase; Stearoyl-CoA Desaturase (SCD) | Metabolism |
SCD1 inhibitor-4 是一种具有口服活性的 stearoylCoA desaturase-1 抑制剂,可用于研究糖尿病。 | |||
T12863 |
SCD1 inhibitor-1
|
Others | Others |
SCD1 inhibitor-1 is a potent and liver-selective inhibitor of stearoyl-CoA desaturase-1 (SCD1). | |||
T2650 |
MK-8245
|
Dehydrogenase; Stearoyl-CoA Desaturase (SCD) | Metabolism |
MK8245 是肝靶向的硬脂酰 -CoA 去饱和酶(SCD)抑制剂,对人 SCD1 和鼠 SCD1 的IC50值分别为 1 nM 和 3 nM,具有抗糖尿病和抗血脂异常的作用。 | |||
T9003 |
CVT-11127
N-[2-[6-[[(3,4-二氯苯基)甲基]氨基]-2-(4-甲氧基苯基)-3-氧代-3,4-二氢吡啶并[2,3-B]吡嗪-4-基]乙基]乙酰胺 |
Dehydrogenase | Metabolism |
CVT-11127 是 SCD 抑制剂。它将细胞周期阻滞在 G1/S 期,诱导细胞凋亡。它可用于肺癌的研究。 | |||
T4515 |
A939572
|
Dehydrogenase; Stearoyl-CoA Desaturase (SCD) | Metabolism |
A939572 是口服具有活性的硬脂酰 CoA 去饱和酶 1SCD1抑制剂,对mSCD1和hSCD1的IC50分别为 <4 nM 和 37 nM。 | |||
T16068 |
MF-438
|
Dehydrogenase; Stearoyl-CoA Desaturase (SCD) | Metabolism |
MF-438 是一种口服具有活力的 stearoyl-CoA desaturase 1 抑制剂,其对 rSCD1 的 EC50值为 2.3 nM。 | |||
T1869 |
PluriSIn 1
4-吡啶羧酸 2-苯基酰肼,NSC 14613,PluriSIn #1,PluriSln 1 |
Apoptosis; Dehydrogenase; Stearoyl-CoA Desaturase (SCD) | Apoptosis; Metabolism |
PluriSIn 1 (NSC 14613) 是一种酰基-辅酶 A 去饱和酶抑制剂,是一种多能细胞特异性的抑制剂。 | |||
T13356 |
XEN723
|
Dehydrogenase; Stearoyl-CoA Desaturase (SCD) | Metabolism |
XEN723 是新型的硬脂酰辅酶 A 去饱和酶的噻唑基咪唑烷酮抑制剂,能够抑制小鼠和 HepG2 细胞的活性,它们的 IC50值分别为 45 和 524 nM。 | |||
T9722 |
YTX-465
|
Stearoyl-CoA Desaturase (SCD) | Metabolism |
YTX-465 是有效的硬脂酰辅酶 A 去饱和酶 (Ole1/SCD) 抑制剂,抑制 Ole1 和 SCD1的IC50=分别为 0.039 μM 和 30.4 μM。YTX-465在帕金森病和其他突触核蛋白病领域有研究的价值。 | |||
T14878 |
CAY10566
|
Dehydrogenase; Stearoyl-CoA Desaturase (SCD) | Metabolism |
CAY10566 是选择性的、口服具有活性的硬脂酰辅酶 A 去饱和酶 1 抑制剂,在小鼠和人酶测定中IC50分别为 4.5 和 26 nM。它具有显著的细胞活性,可阻断 HepG2 细胞中饱和长链脂肪酸-CoAs (LCFA-CoAs) 向单不饱和 LCFA-CoAs 的转化 。 | |||
T84804 |
SCD1/5-IN-1
|
Others | Others |
SCD1/5-IN-1 (Compound 10) 作为一种SCD1/5抑制剂,适用于神经系统疾病的研究。 | |||
T61841 |
SCD1-IN-1
|
Others | Others |
SCD1-IN-1, a potent inhibitor of SCD1 (IC50: 5.8 nM), is valuable in dermatologic research [1]. | |||
T38844 |
MK-8245 Trifluoroacetate
|
Others | Others |
MK-8245 trifluoroacetate is a liver-targeting inhibitor of stearoyl-CoA desaturase (SCD) with IC50 of 1 nM for human SCD1 and 3 nM for both rat SCD1 and mouse SCD1, with anti-diabetic and anti-dyslipidemic efficacy. IC50 value: 1 nM (hSCD1) Target: SCD1 in vitro: MK-8245, a phenoxy piperidine isoxazole derivative, has been identified as a potent and liver-specific SCD inhibitor. It contains a tetrazole acetic acid moiety, which is the key molecule for OATPs recognition and liver-targeting. MK... | |||
T79262 |
SSI-4
|
Stearoyl-CoA Desaturase (SCD) | Metabolism |
SSI-4为SCD1 (硬脂酰辅酶A去饱和酶1) 抑制剂,能够通过11C标记,用于SCD1体内小动物PET/CT成像的配体。 |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T41253 |
Sterculic acid
|
Others | Others |
Sterculic acid 是一种硬脂酰辅酶 A 去饱和酶 1 (SCD1) 抑制剂。Sterculic acid 剂量依赖性抑制 delta-9 去饱和酶 (Δ9D) 活性,IC50值为 0.9 μM。 |